Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.
HIV prevention drug hailed as breakthrough, but who gets access?
Trending
- Is Trumponomics working? Inflation growth outpacing wage growth
- Will the midterms be a blue wave? Senate ‘very much up for grabs’: Bill Kristol
- "I want the TRUTH" NY Gov. appoints special prosecutor in Cornell case
- Answers with Andrew Weissmann — What happens if Mike Johnson refuses to certify the election?
- Trump’s White House A.I. accidentally tells the truth
- Braves vs. Dodgers: Breaking down the 2026 season series
- The biggest question facing every ALDS team
- Yankees vs. Rays: Breaking down the 2026 season series
